{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:03:03Z","timestamp":1777777383458,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06477-x","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:55:29Z","timestamp":1777488929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HDHD5 promotes triple-negative breast cancer growth and drives EMT-associated phenotypes via regulating S100A4"],"prefix":"10.1007","volume":"152","author":[{"given":"Jia-Yang","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Ke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Min","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"2","key":"6477_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L (2022) Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol 19(2):91\u2013113","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"6477_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13(11):674\u2013690","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6477_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S et al (2022) Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol 15(1):121","journal-title":"J Hematol Oncol"},{"issue":"6","key":"6477_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148(6):1145\u20131159","journal-title":"Cell"},{"issue":"3\u20134","key":"6477_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10495-022-01709-0","volume":"27","author":"P Tanprasert","year":"2022","unstructured":"Tanprasert P, Limpakan Yamada S, Chattipakorn SC, Chattipakorn N, Shinlapawittayatorn K (2022) Targeting mitochondria as a therapeutic anti-gastric cancer approach. Apoptosis 27(3\u20134):163\u2013183","journal-title":"Apoptosis"},{"issue":"1","key":"6477_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/15548627.2024.2392415","volume":"21","author":"Z Xiong","year":"2025","unstructured":"Xiong Z, Yang L, Zhang C, Huang W, Zhong W, Yi J et al (2025) MANF facilitates breast cancer cell survival under glucose-starvation conditions via PRKN-mediated mitophagy regulation. Autophagy 21(1):80\u2013101","journal-title":"Autophagy"},{"issue":"1","key":"6477_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12967-025-06080-7","volume":"23","author":"T Xu","year":"2025","unstructured":"Xu T, Chu C, Xue S, Jiang T, Wang Y, Xia W et al (2025) Identification and validation of a prognostic signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancer. J Transl Med 23(1):131","journal-title":"J Transl Med"},{"key":"6477_CR8","doi-asserted-by":"publisher","first-page":"1489444","DOI":"10.3389\/fimmu.2024.1489444","volume":"15","author":"P Ding","year":"2024","unstructured":"Ding P, Pei S, Qu Z, Yang Y, Liu Q, Kong X et al (2024) Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer. Front Immunol 15:1489444","journal-title":"Front Immunol"},{"issue":"1","key":"6477_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13058-025-02153-z","volume":"27","author":"S Yu","year":"2025","unstructured":"Yu S, Zhou Y, Zhang S, He F, Jiang L, Lv X et al (2025) The role and prognostic value of mitochondria-related gene PARK7 in breast cancer. Breast Cancer Res 27(1):200","journal-title":"Breast Cancer Res"},{"issue":"3","key":"6477_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X et al (2019) Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. Cancer Cell 35(3):428\u201340e5","journal-title":"Cancer Cell"},{"issue":"4","key":"6477_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s43018-024-00725-0","volume":"5","author":"YZ Jiang","year":"2024","unstructured":"Jiang YZ, Ma D, Jin X, Xiao Y, Yu Y, Shi J et al (2024) Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities. Nat Cancer 5(4):673\u2013690","journal-title":"Nat Cancer"},{"key":"6477_CR12","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.phrs.2022.106210","volume":"179","author":"X Jiang","year":"2022","unstructured":"Jiang X, Xu Z, Yao D, Liu X, Liu W, Wang N et al (2022) An integrated multi-omics approach revealed the regulation of melatonin on age-dependent mitochondrial function impair and lipid dyshomeostasis in mice hippocampus. Pharmacol Res 179:106210","journal-title":"Pharmacol Res"},{"key":"6477_CR13","doi-asserted-by":"publisher","first-page":"1669678","DOI":"10.3389\/fimmu.2025.1669678","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang H, Zhang K, Wang Y, Chen M, Zhang M (2025) A mitochondrial lipid metabolism-related gene signature predicts prognosis and immune landscape in colorectal cancer. Front Immunol 16:1669678","journal-title":"Front Immunol"},{"issue":"D1","key":"6477_CR14","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ et al (2021) MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res 49(D1):D1541\u2013d7","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"6477_CR15","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509\u2013w14","journal-title":"Nucleic Acids Res"},{"key":"6477_CR16","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gy\u0151rffy","year":"2021","unstructured":"Gy\u0151rffy B (2021) Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J 19:4101\u20134109","journal-title":"Comput Struct Biotechnol J"},{"key":"6477_CR17","doi-asserted-by":"crossref","unstructured":"Kwon MR, Park JS, Ko EJ, Park J, Ju EJ, Shin SH et al (2024) Ibulocydine Inhibits Migration and Invasion of TNBC Cells via MMP-9 Regulation. Int J Mol Sci. ;25(11)","DOI":"10.3390\/ijms25116123"},{"key":"6477_CR18","doi-asserted-by":"crossref","unstructured":"B\u0142aszczak E, Miziak P, Odrzywolski A, Baran M, Gumbarewicz E, Stepulak A (2025) Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial-Mesenchymal Transition. Cancers (Basel). ;17(2)","DOI":"10.3390\/cancers17020228"},{"issue":"19","key":"6477_CR19","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1158\/0008-5472.CAN-17-1294","volume":"77","author":"KH Chow","year":"2017","unstructured":"Chow KH, Park HJ, George J, Yamamoto K, Gallup AD, Graber JH et al (2017) S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma. Cancer Res 77(19):5360\u20135373","journal-title":"Cancer Res"},{"issue":"5","key":"6477_CR20","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41418-023-01126-z","volume":"30","author":"RRJ Low","year":"2023","unstructured":"Low RRJ, Fung KY, Gao H, Preaudet A, Dagley LF, Yousef J et al (2023) S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer. Cell Death Differ 30(5):1155\u20131165","journal-title":"Cell Death Differ"},{"key":"6477_CR21","doi-asserted-by":"crossref","unstructured":"Deng D, Begum H, Liu T, Zhang J, Zhang Q, Chu TY et al (2024) NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer. J Exp Med. ;221(11)","DOI":"10.1084\/jem.20240766"},{"key":"6477_CR22","doi-asserted-by":"publisher","first-page":"115623","DOI":"10.1016\/j.biopha.2023.115623","volume":"167","author":"M Zhang","year":"2023","unstructured":"Zhang M, Barroso E, Ruart M, Pe\u00f1a L, Peyman M, Aguilar-Recarte D et al (2023) Elafibranor upregulates the EMT-inducer S100A4 via PPAR\u03b2\/\u03b4. Biomed Pharmacother 167:115623","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6477_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of Cancer: New Dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"issue":"7","key":"6477_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrclinonc.2015.73","volume":"12","author":"D Zardavas","year":"2015","unstructured":"Zardavas D, Irrthum A, Swanton C, Piccart M (2015) Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol 12(7):381\u2013394","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6477_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-021-00579-3","volume":"6","author":"H Sun","year":"2021","unstructured":"Sun H, Wang C, Hu B, Gao X, Zou T, Luo Q et al (2021) Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3. Signal Transduct Target Ther 6(1):187","journal-title":"Signal Transduct Target Ther"},{"key":"6477_CR26","doi-asserted-by":"publisher","first-page":"101211","DOI":"10.1016\/j.drup.2025.101211","volume":"79","author":"YY Yan","year":"2025","unstructured":"Yan YY, Deng ZF, Wu XT, Lu Y, Zhu ZY, Wen Q et al (2025) Low miR-224-5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4. Drug Resist Updat 79:101211","journal-title":"Drug Resist Updat"},{"issue":"1","key":"6477_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","volume":"13","author":"N Abdelfattah","year":"2022","unstructured":"Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R et al (2022) Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun 13(1):767","journal-title":"Nat Commun"},{"issue":"1","key":"6477_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41419-025-08072-3","volume":"16","author":"H Hu","year":"2025","unstructured":"Hu H, Bai H, Wang C, Xi L, Tian S, Ni M et al (2025) Super enhancer lncRNA RP11-54O7.17 regulates the proliferation and metastasis of triple-negative breast cancer by targeting lysosomal degradation of S100A4. Cell Death Dis 16(1):773","journal-title":"Cell Death Dis"},{"issue":"3","key":"6477_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s43018-023-00524-z","volume":"4","author":"WY Park","year":"2023","unstructured":"Park WY, Gray JM, Holewinski RJ, Andresson T, So JY, Carmona-Rivera C et al (2023) Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway. Nat Cancer 4(3):419\u2013435","journal-title":"Nat Cancer"},{"issue":"3","key":"6477_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1158\/0008-5472.CAN-16-1802","volume":"77","author":"TM Ismail","year":"2017","unstructured":"Ismail TM, Bennett D, Platt-Higgins AM, Al-Medhity M, Barraclough R, Rudland PS (2017) S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer. Cancer Res 77(3):780\u2013789","journal-title":"Cancer Res"},{"issue":"7","key":"6477_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41419-023-05911-z","volume":"14","author":"A Liu","year":"2023","unstructured":"Liu A, Li Y, Lu S, Cai C, Zou F, Meng X (2023) Stanniocalcin 1 promotes lung metastasis of breast cancer by enhancing EGFR-ERK-S100A4 signaling. Cell Death Dis 14(7):395","journal-title":"Cell Death Dis"},{"issue":"19","key":"6477_CR32","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1111\/febs.14090","volume":"284","author":"M Sciacovelli","year":"2017","unstructured":"Sciacovelli M, Frezza C (2017) Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer. Febs j 284(19):3132\u20133144","journal-title":"Febs j"},{"issue":"3","key":"6477_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.celrep.2014.06.043","volume":"8","author":"PE Porporato","year":"2014","unstructured":"Porporato PE, Payen VL, P\u00e9rez-Escuredo J, De Saedeleer CJ, Danhier P, Copetti T et al (2014) A mitochondrial switch promotes tumor metastasis. Cell Rep 8(3):754\u2013766","journal-title":"Cell Rep"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06477-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06477-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:55:31Z","timestamp":1777488931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06477-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6477"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06477-x","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"101"}}